Filed:
Filed by person(s) reporting owned shares of common stock in a public company
>5%
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
W4ashington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
TRIMEDYNE, INC.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
896259-10-8
(CUSIP Number)
Steven Morse, Esq., Morse & Morse, PLLC, 1400 Old Country Road,
Suite 302, Westbury, NY 11590 (516-487-1446)
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
February 15, 2006
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with the statement [ ].
(A fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange
Act("ACT") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP NO.: 896259-10-8 PAGE 2
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
1 Lynne Kanofsky
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /X/
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e)
/ /
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 455,433
BENEFICIALLY -----------------------------------------------------------
OWNED BY
EACH 8 SHARED VOTING POWER
REPORTING
PERSON -----------------------------------------------------------
WITH
9 SOLE DISPOSITIVE POWER
455,433
-----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
455,433
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/ /
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.1%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
CUSIP NO.: 896259-10-8 PAGE 3
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
1 Bruce J. Haber
--------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) /X/
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e)
/ /
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 476,220
BENEFICIALLY -----------------------------------------------------------
OWNED BY
EACH 8 SHARED VOTING POWER
REPORTING -----------------------------------------------------------
PERSON
WITH 9 SOLE DISPOSITIVE POWER
476,220
-----------------------------------------------------------
10 SHARED DISPOSITIVE POWER
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
476,220
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/ /
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.3%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
CUSIP NO.: 896259-10-8 PAGE 4
Item 1. Security and Issuer
This statement relates to the shares of Common Stock, of Trimedyne, Inc. (the
"Issuer"). The Issuer's principal executive office is located at 15091 Bake
Parkway, Irvine, CA 92618.
Item 2. Identity and Background
Lynne Kanofsky
(a) Lynne Kanofsky
(b) 1 Mud Pond Trail, Stockholm, NJ 07460
(c) Accountant
(d) Not applicable
(e) Not applicable
(f) U.S.A Bruce J. Haber
(a) Bruce J. Haber
(b) c/o BJH Management, LLC 145 Huguenot Street, Suite 405, New Rochelle, NY
10801
(c) Private Investor
(d) Not applicable
(e) Not applicable
(f) U.S.A.
Item 3. Source and Amount of Funds or Other Consideration Personal funds. Item
4. Purpose of Transactions
The purpose of the acquisition of securities of the Issuer is for personal
investment. At this time, the reporting persons have no plans or proposals which
relate to or would result in items (a) through (j), except for their intention
to purchase a presently undetermined amount of additional securities of the
Issuer.
Item 5. Interest in Securities of the Issuer
(a) (b) As disclosed in the Issuer's Form 10-QSB for the quarter ended March
31, 06, there were 14,628,302 shares outstanding. Of that total, as of June 19,
2006, Lynne Kanofsky and Bruce J. Haber have the sole right and power to vote
and dispose of 455,433 shares and 476,220 shares, respectively, representing
3.1% and 3.3% of the Issuer's outstanding shares or an aggregate total as a
group of 931,653 shares or 6.4% of the outstanding shares.
(c)In the last 60 days, Lynne Kanofsky purchased 34,100 shares at prices ranging
from $.84 to $1.09 per share. Over the same time period, Mr. Haber purchased
40,150 shares at prices ranging from $.84 to $1.10 per share. (d) & (e) Not
Applicable Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to the Securities of the Issuer N/A Item 7. Materials to be filed as
Exhibits N/A
Signatures
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: June 19, 2006
Reporting Person: Lynne Kanofsky
Signature: /s/ Lynne Kanofsky
--------------------
Lynne Kanofsky
Reporting Person: Bruce J. Haber
Signature: /s/ Bruce J. Haber
---------------------
Bruce J. Haber